|4Mar 24, 5:00 PM ET

CUMBERLAND PHARMACEUTICALS INC 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 24, 2017

Insider Transaction Report

Form 4
Period: 2017-03-23
Bonner Michael
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-03-23$6.42/sh+900$5,77812,800 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION